Translating emerging therapeutics into clinical use
Are the latest drugs fit for purpose in MAPK/ERK and PI3K signalling pathways?
Date
21 Dec 2015Session
Translating emerging therapeutics into clinical usePresenters
Fortunato CiardielloAuthors
F. CiardielloAuthor affiliations
- Second University of Naples, 80131 - Naples/IT
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Manipulating immune system in GI cancer
Presenter: Benoit van den Eynde
Session: Translating emerging therapeutics into clinical use
Resources:
Slides
Webcast
Targeting angiogenesis in GI cancers
Presenter: Kei Muro
Session: Translating emerging therapeutics into clinical use
Resources:
Slides
Webcast
What lessons can we learn from targeting cMET and IGFR in GI cancers?
Presenter: Ian Chau
Session: Translating emerging therapeutics into clinical use
Resources:
Slides
Webcast